INTRODUCTION
============

Many metazoan cells are polarized. Polarization usually precedes and enables asymmetric cell divisions that generate cell diversity. In the *Caenorhabditis elegans* embryo, cell polarization determines the pattern of cell cleavages that produce the number and diversity of cells to constitute a functional worm. Many asymmetric cleavages, including the first, occur in cells that exhibit a polarized distribution of a subset of the PAR proteins, which are necessary for cytoplasmic *par*titioning ([@B13]). Because the PAR proteins constitute a conserved molecular machine, insight into their segregation and mode of action may be generally applicable to many organisms.

The *C. elegans* embryo establishes its anterioposterior (A--P) body axis before the first embryonic cleavage: the site of sperm entry defines the posterior end of the major axis of the fertilized oocyte ([@B12]). This polarizing activity requires a functional centrosome ([@B41]; [@B31]; [@B17]) but not the sperm nucleus ([@B37]) or many microtubules ([@B8]; [@B49]). The cortical actomyosin cytoskeleton becomes activated during meiosis II, generating motile ruffles throughout the cortex. The polarizing cue directs cortical flows away from the sperm pronucleus--centrosome complex. These actomyosin-powered flows transport cortical components toward the anterior, accompanied by the smoothing of the posterior cortex. The flows can give rise to a transient cortical invagination, called a pseudocleavage furrow ([@B30]), which marks the boundary between distinct anterior and posterior cortical domains in wild-type embryos, although it is neither required for polarization nor is an inevitable consequence of flows ([@B36]; [@B28]). The period from the onset of flows to the resolution of the pseudocleavage furrow comprises the establishment phase ([@B10]).

Two sets of cytoplasmic determinants segregated by the cortical flows transduce the polarity cue to downstream effectors. The proteins PAR-3, PAR-6, and PKC-3 accumulate to the anterior of the pseudocleavage furrow, whereas the posterior domain contains PAR-2 and PAR-1. After the resolution of the pseudocleavage furrow, these two sets of proteins are mutually exclusive for localization: the anterior PARs are generally required for the others\' anterior localization, and the posterior PARs prevent the anterior PARs from expanding into the posterior domain after the cessation of cortical flows ([@B10]). The period in which the PAR proteins are mutually antagonistic is termed the maintenance phase ([@B10]). The PAR proteins are required to orient and position the first mitotic spindle, thereby defining the division plane, and to direct differential gene expression in the resulting daughter cells ([@B14]). *cdc-42* is required to maintain PAR protein polarity and was the first Rho family member implicated in the polarization of the *C. elegans* embryo ([@B15]; [@B26]).

The Rho-family of small GTPases function as molecular switches such that their guanosine triphosphate (GTP)-bound forms activate downstream effector molecules, whereas their guanosine diphosphate (GDP)-bound forms do not. These proteins themselves are regulated by guanine nucleotide exchange factors (GEFs) that catalyze their activation, and GTPase activating proteins (GAPs) that catalyze their inactivation. In *C. elegans*, RHO-1 and CDC-42 are the only members of their respective subfamilies, and both are required for proper development of the one-cell embryo. RHO-1 activity is required for the cortical contractility observed during the establishment of embryonic polarization; the localization of this activity likely patterns the flows that segregate cortical determinants. Embryos depleted of RHO-1 or its putative GEF ECT-2 ([@B24]; [@B29]; [@B40]), myosin II ([@B16]; [@B42]), or filamentous actin ([@B19]) do not exhibit wild-type ruffling, cortical myosin recruitment, or cortical flows during the establishment phase. In contrast, embryos depleted either of proteins required for centrosome maturation or the paternal contribution of the RhoGAP CYK-4 ([@B24]) exhibit cortical ruffling and myosin recruitment but no observable cortical flows. Together, these observations suggest that RHO-1 activity initially signals myosin-mediated contractility of the entire cortex, which is reduced at the presumptive posterior in response to the centrosome-mediated polarity cue. The transduction of this cue may involve a localized high concentration of RhoGAP activity in the form of paternal CYK-4 ([@B24]) and a localized reduction in RhoGEF activity due to a reduction of the local ECT-2 concentration ([@B29]). The subsequent asymmetric contractility results in the retraction of the cortex toward the anterior half of the embryo and the creation of a noncontractile cortical domain at the posterior half. Experimental manipulation of RHO-1 activity can affect the relative sizes of the contractile and noncontractile domains during polarization but does not appreciably affect the ultimate distribution of anterior and posterior markers during first cleavage ([@B38]; [@B39]). This suggests that although the regulation of RHO-1 activity during the establishment phase is required to polarize the cell, it does not determine the extent of anterior or posterior characterization of the cell by the time of cleavage.

In contrast to RHO-1 activity, CDC-42 activity is required to maintain PAR polarity during maintenance phase and has only subtle effects during establishment phase. In maintenance phase, CDC-42--depleted embryos exhibit a cortical loss of the anterior PAR proteins ([@B15]). PAR-6 is lost from the anterior during this phase in most *cdc-42(fRNAi)* embryos ([@B1]; [@B29]) and may be lost well before polarization in stronger depletions ([@B40]). This loss of cortical PAR-6, and concomitant expansion of the posterior PAR proteins into the anterior, is probably the cause of the observed defects in pronuclear rotation, asymmetric spindle and furrow positioning, and proper developmental determination of daughter cells. In the wild type, stabilization of PAR-6 at the cortex is mediated by direct interaction of PAR-6 with the active form of CDC-42 ([@B1]), although a CDC-42--independent mechanism for PAR-6 also operates ([@B5]). This stabilization may occur by the activation of the anterior PAR complex, whose PKC-3 activity directly phosphorylates and effectively excludes the local persistence of the posterior PAR protein PAR-2 ([@B18]), which is in turn necessary to maintain PAR-1 at the posterior. Depletion of CDC-42 reduces the depth and persistence of cortical invaginations and reduces the rate of myosin flow in the establishment phase ([@B29]; [@B40]). These embryos nonetheless exhibit successful anteriorward actomyosin flows. Thus, the essential polarity function of CDC-42 seems to occur in maintenance rather than establishment phase. How CDC-42 is regulated in developmental time and space to permit the maintenance of polarity is not well understood. In this study, we have characterized spatial activity patterns of CDC-42 and identified regulators that give rise to these patterns.

MATERIALS AND METHODS
=====================

Worm Stocks and Maintenance
---------------------------

Worm strains were maintained as described previously ([@B7]). The following stains were used: Bristol N2 (wild type), DP38 (*unc-119(ed3) III*.), WH333 (*unc-119(ed3) III; ojIs26*\[*unc-119(*+*) Ppie-1::gfp::nmy-2*\]), KK288 (bears *itIs153*, which includes a *Ppie-1::gfp::par-2* transgene), TH25 (expresses GFP::PAR-6 in germline), FX1909 (*chin-1(tm1909 or* +*)/*+ *III*.), VC506 (*cgef-1(gk261) X*.), and VC315 (+/*eT1 III; mrck-1(ok586)/eT1 V*.). FX1909 and VC506 were outcrossed six generations to N2 males. Then, *gk261* animals were isolated, and *tm1909* was balanced with the *sC1* chromosome from strain KK747 \[*par-2(lw32) unc-45(e286ts)/sC1*\[*dpy-1(e1) let-??*\] *III*.\]. VC315 were outcrossed three generations to N2 males, and then *ok586* animals were balanced with the *nT1*\[*qIs51*\] chromosome that had been outcrossed to N2 for five generations from strain VC666.

Fluorescent Protein (FP) Strain Constructions
---------------------------------------------

Transgenic lines used in this study were generated by bombardment of *unc-119(*+)-containing plasmids as described previously ([@B33]). We subcloned the portion of the *wsp-1* open reading frame (ORF) encoding amino acids 236-346 of isoform a from plasmid yk1350a08 (gift from Y. Kohara, National Institute of Genetics, Mishima, Japan) into the SpeI site of plasmid pFJ1.1 to drive expression of green fluorescent protein (GFP)-tagged GBDwsp-1 by using the *pie-1* promoter and untranslated regions (UTRs). This plasmid (GenBank accession [FJ602701](FJ602701)) also contained an *unc-119(*+) transgene. To facilitate expression of mCherry as well as a monomeric mutant of GFP (mGFP) we constructed new plasmids from pFJ1 suitable for expressing N-terminally FP-tagged transgenes under the regulatory control of the *pie-1* promoter and UTRs. In brief, this was done by removing the residual *pie-1* ORF from pFJ1.1 and replacing the *gfp* sequence with sequences containing *mgfp* or *mcherry. mgfp* was generated by site-directed mutagenesis (using the QuikChange protocol from Stratagene, La Jolla, CA) of pFJ1.1-derived *gfp* sequence to induce an A206K mutation. A silent mutation was introduced into *mcherry* sequence (gift from A. Audhya, University of Wisconsin--Madison, Madison, WI) to remove a MluI site. These FP-encoding fragments were amplified by polymerase chain reaction (PCR) to append flanking BamHI sites and tandem SpeI and MluI sites just inside the 3′ BamHI site. These fragments were subcloned into the BamHI sites of the *pie-1* ORF-deleted version of pFJ1.1. The resulting pJK3 and pJK6 vectors permit subcloning of SpeI--MluI-flanked inserts to yield plasmids suitable for expressing N-terminally tagged mGFP or mCherry under the control of *pie-1* promoter and UTRs as well as an *unc-119(*+) rescuing fragment for transformant selection. We subcloned the ORF and introns of *cdc-42* from N2 genomic DNA, full-length ORFs of *cdc-42(T17N)* and *cdc-42(Q61L)* from pJAM:yfpcdc42(T17N) and pJAM:yfpcdc42(Q61L) (gifts from D. Aceto and K. Kemphues, Cornell University, Ithaca, NY), ORF of *cgef-1a* from yk110c3, and the ORF and introns of *chin-1* from N2 genomic DNA between the SpeI and MluI sites of pJK3 and pJK6. In this article, *mgfp* genes and mGFP fusions are written as "*gfp*" and "GFP" for simplicity.

Yeast Two-Hybrid Interaction Studies
------------------------------------

Yeast two-hybrid studies were performed using the MatchMaker two-hybrid system (Clontech, Mountain View, CA), by using manufacturer\'s protocols, except as noted. The ORFs of *cdc-42*, *cdc-42(T17N)*, *cdc-42(Q61L)*, and *GBD~WSP~-~1~* were subcloned into pGADT7 and pGBKT7 vectors that were modified such their respective NdeI--XhoI and NdeI--PstI fragments were replaced with SpeI--AscI and SpeI--MluI tandem cloning sites. The mutant *cdc-42* sequences were gifts from D. Aceto and K. Kemphues. All two-hybrid experiments were performed in the AH109 strain, grown for 5 d at 30°C by using the His marker to test interaction.

RNA-mediated Interference (RNAi) Treatment
------------------------------------------

RNAi was performed by a previously described feeding method ([@B47]). In brief, HT115(DE3) Escherichia coli were transformed with a pL4440-based vector bearing T7 promoters useful for bacterial production of double-stranded RNA (dsRNA) of the intervening sequence of interest. These bacteria were induced to transcribe dsRNA for 1 d on nematode growth media plates containing isopropyl β-[d]{.smallcaps}-thiogalactoside (IPTG); to deplete two genes, bacterial strains were mixed at a 1:1 ratio based on the cultures\' optical densities. Worms were then fed these bacteria for 20--50 h before dissection of their embryos for imaging. Unless otherwise noted, constructs used to induce RNAi were obtained from a previously published collection produced by the Ahringer laboratory ([@B25]). Other constructs were produced by subcloning cDNA sequences into pL4440. The cDNA clones used (gifts from Y. Kohara) include yk196b9 (for *par-1*), yk325e4 (*par-2*), yk552e12 (*par-3*), yk109f2 (*cdc-42*), yk110c3 (*cgef-1*), yk1083a11 (*Y105E8A.24*), yk1243d09 (*Y95B8A.12*), yk877c07 (*rhgf-1*), yk881c01 (*Y34B4A.8*), yk146f7 (*rga-4*), yk677g10 (*2RSSE.1*), and yk1707c12 (*chin-1*). All constructs presented were confirmed by sequencing to bear the target gene or cDNA. Embryos depleted of these gene products necessary for asymmetric cell division were imaged to the four-cell stage to demonstrate efficacy of RNAi treatment. For CHIN-1 immunolocalization, HT115(DE3) E. coli were transformed with a plasmid designed to express dsRNA corresponding to either *chin-1* or the nonessential gene *smd-1* and were induced to transcribe dsRNA on MYOB plates containing IPTG. N2 strain L1-stage larvae were transferred onto these plates and grown for 3 d. Adult worms were then dissected to obtain young embryos for immunostaining.

Statistical Analysis
--------------------

The analysis of interactions of *cgef-1* with other GEF-encoding genes was performed via logistic regression by using the statistical computing program R, version 2.7.1 ([@B35]), assuming a binomial outcome for survival to hatching.

Antibody Production
-------------------

Affinity-purified rabbit sera produced against amino acids 137-236 of CHIN-1 and 256-375 of CGEF-1A were produced by Strategic Diagnostics (Newark, DE), by using genomic antibody technology.

Immunostaining
--------------

Embryos were fixed for 10 min at −20°C in *N*,*N*-dimethylformamide, and then briefly washed in 1× phosphate-buffered saline (PBS)/0.5% Tween/2 mM MgCl~2~ before blocking. The anti-α tubulin antibody DMA1 (Sigma-Aldrich, St. Louis, MO) was used at 1:1000 dilution and anti-CHIN-1 antibody at 1:4000. Isopropyl β-[d]{.smallcaps}-thiogalactoside was used to counterstain DNA. Staining of DNA and tubulin were used to establish embryonic staging.

Imaging
-------

Embryos and animals for imaging were prepared either by mounting embryos on a 2% agar pad or in a hanging drop of egg buffer with subsequent sealing with Vaseline (Chesebrough-Ponds, Greenwich, CT) or by anesthetizing worms in M9 supplemented with 5 mM levamisole (Sigma-Aldrich) and mounting on a 5% agar pad with subsequent sealing with Vaseline. Multiphoton-excitation laser scanning microscopy (MPLSM) was performed with two previously described ([@B52]; [@B44]), custom-built microscope systems. The MPLSM excitation sources were Ti:Sapphire lasers (Coherent Mira, Santa Clara, CA) or Spectra Physics Tsunami (Mountain View, CA) tuned to an excitation wavelength of 890 nm. The detectors were H7422P-40 GaAsP photomultiplier tubes (Hamamatsu, Hamamatsu City, Japan). Objectives used were a Super Fluor 40× 1.3 numerical aperture (NA) for imaging GFP::GBD~wsp-1~ and a Super Fluor 100× 1.3NA for all other probes (Nikon, Melville, NY). The MPLSMs achieve maximal resolution with the 100× objective. Images were collected at 512 × 512 pixel resolution with laboratory-developed acquisition software (WiscScan) and were analyzed with ImageJ (National Institutes of Health, Bethesda, MD). For immunolocalization of CHIN-1 and CGEF-1, confocal microscopy was performed as described previously ([@B45]).

For fluorescence resonance energy transfer (FRET) studies, embryos were dissected from single mothers in egg buffer and mounted on a 2% agar pad. Mothers were the cross-progeny of mating WH363 (a line bearing an integrated *Ppie-1::gfp::GBDwsp-1* transgene) males with WH423 \[a line bearing nonintegrated *Ppie-1::mcherry::CDC-42(Q61L)* transgenes\] or WH432 \[a line bearing nonintegrated *Ppie-1::mcherry::CDC-42(T17N)* transgenes\] hermaphrodites. Fluorescence lifetime measurements were made on a previously described ([@B43]), custom-built MPLSM by using an SPC-830 time-correlated, single-photon counting (TCSPC) module (Becker & Hickl, Berlin, Germany) for fluorescence lifetime imaging microscopy (FLIM). After lifetime data collection, embryos were scored for presence or absence of mCherry expression by visual inspection via wide-field fluorescence microscopy. Data were analyzed with TCSPC analysis software (SPCImage v2.8.6.2936; Becker & Hickl) and Excel 2003 (Microsoft, Redmond, WA). For lifetime determinations, scatter was set to 0 and shift was optimized for best fit at the brightest pixel within an embryo when integration was set to 10.

Active CDC-42 Probe Construction, Validation, and Localization Pattern
----------------------------------------------------------------------

To monitor the spatiotemporal activity of CDC-42 in the early embryo, we identified a G-protein binding domain (GBD) of the *C. elegans* homologue of the Wiskott-Aldrich Syndrome protein WSP-1. The CRIB domain of WSP-1 binds specifically to GTP-bound (active) CDC-42. The alignment of WSP-1, vertebrate homologues of WSP-1, and a previously described biosensor that reports Cdc42 activity in *Xenopus* oocytes ([@B6]; [Figure 1](#F1){ref-type="fig"}A) identified a fragment that includes a predicted CRIB domain, which was sufficient for specific binding to GTP-bound CDC-42. This specific binding activity was confirmed first by interaction in a yeast two-hybrid system. The putative GBD demonstrated interaction with wild-type CDC-42 and a constitutively active mutant CDC-42(Q61L) but not with a constitutively inactive mutant CDC-42(T17N) or the analogous mutations of the Rho-family GTPases CED-10/Rac and RHO-1 ([Figure 1](#F1){ref-type="fig"}D). We confirmed the interaction in vivo using a FRET/FLIM approach. FRET was observed between GFP-tagged GBD~WSP-1~ and mCherry-tagged CDC-42(Q61L) but not between GFP::GBDwsp-1 and mCherry::CDC- 42(T17N). In this approach, interaction of fluorophores colocalizing on the order of 5 nm reduces the fluorescence lifetime of the donor fluorophore. Unexpectedly, the gene dose of GFP::GBDwsp-1 had a small but statistically significant effect (2569ps and 2526ps for 2 and 1 gene copies, respectively; 0.01 \< p \< 0.02) on observed GFP lifetime, so all comparisons were made using embryos expressing GFP::GBDwsp-1 from a single genetic copy. Embryos coexpressing one gene copy GFP::GBDwsp-1 and either mCherry::CDC-42(T17N) or mCherry::CDC- 42(Q61L) exhibited GFP lifetimes of 2523ps (p \> 0.80) and 2444ps (p \< 0.01), respectively (Supplemental Figure 1). Thus, FRET analysis suggests that GBDwsp-1 interacts directly with CDC-42(Q61L) but not CDC-42(T17N) probe in vivo.

Transgenic worms that express a GFP-tagged GBD~WSP-1~ in the germline and early embryo permitted a spatiotemporal localization of CDC-42 activity by fluorescence microscopy. Fluorescence signal from GFP::GBD~WSP-1~ was observed at the cell cortices of the germline and young embryos (data not shown; [Figure 1](#F1){ref-type="fig"}B and Supplemental Movie 1). RNAi-mediated depletions of CDC-42 abolished the detectible cortical enrichment ([Figure 1](#F1){ref-type="fig"}C and Supplemental Movie 2). In these embryos, GFP::GBD~WSP-1~ localized throughout the cytoplasm and was enriched in the nucleoplasm. These localizations were similar to those exhibited by embryos expressing unfused GFP (data not shown). Given the demonstrations of specificity of GBD~WSP-1~ for the active form of CDC-42 in vitro and in vivo and the dependence upon CDC-42 for its GFP-tagged fusion protein, we interpret the cortical mobilization of the probe to reflect accessible, active CDC-42 and refer to this mobilization simply as "CDC-42 activity."

RESULTS
=======

Localization of CDC-42 and Its Active and Inactive Mutant Forms
---------------------------------------------------------------

Observations of the dynamic localization of polarity proteins with overexpressed, GFP-tagged transgenes revealed that CDC-42 and subsets of the PAR proteins are required for different phases of polarization in the *C. elegans* one-cell embryo ([@B10]; [@B29]; [@B40]). In our transgenic lines, localizations of GFP-tagged CDC-42 and two of its mutant forms were consistent with those published previously. GFP::CDC-42 was observed to be enriched at all points on the cortex (relative to the cytoplasm) throughout the first cell cycle, but this enrichment was not uniform (Supplemental Figure 2). From polarity initiation through resolution of the pseudocleavage furrow, the cortical localization was enriched at the anterior cortex consistent with movement by bulk flow of the cortex at this time. This localization is largely consistent with those recently published ([@B1]; [@B29]; [@B40]). The anterior enrichment is retained through cytokinesis, where signal is observed most strongly at the apposition of two-cell cortices. GFP::CDC-42 was also enriched in a "cloud" near the sperm centrosome and between the sperm pronucleus and future posterior cortex (Supplemental Movie 1). This cloud flowed away from the polarization site upon initiation of cortical flows. Another novel observation is that signal also localized to the centrosomes and mitotic spindle. The significance of these noncortical localizations is unclear as is their specificity for our transgenic lines. GFP-tagged CDC-42(T17N)---which is likely constitutively inactive ([@B55])---also exhibited a slight cortical enrichment that was polarized at the anterior during cortical flow (Supplemental Figure 2). Between the cessation of cortical flows and onset of cytokinesis, this anterior cortical enrichment was lost, and little cortical localization was observed. By contrast, the GFP-tagged CDC-42(Q61L)---which is likely constitutively active ([@B55])---exhibited enhanced cortical localization and asymmetric cortical enrichment (Supplemental Figure 2). This probe was enriched at the anterior during cortical flow and remained polarized through cytokinesis. Together these observations suggest that CDC-42 activation correlates with increased cortical enrichment as would be predicted by previous descriptions where inactive Rho-family proteins are solubilized by guanosine nucleotide disassociation inhibitors, diffuse to the cytoplasm, and are able to be relocalized to the membrane upon reactivation ([@B21]; [@B11]; [@B20]). Also, the bulk of cortical CDC-42 is enriched at the anterior during cortical flows. However, because the Q61L mutant cycles only very slowly from the active state ([@B53]), the constitutively active CDC-42 mutant localization probably reflects the movement of cortex-ensnared proteins rather than the localization of endogenous CDC-42 activity. Furthermore, the failure of these proteins to cycle their activity state may produce localizations that do not represent the wild-type protein. To avoid these confounding effects, we investigated the localization of endogenous CDC-42 activity by means of an effector-based biosensor approach.

GFP::GBDwsp-1 Localization
--------------------------

CDC-42 activity, as reported by GFP::GBDwsp-1 (see *Materials and Methods* for validation), localized sequentially to the posterior and anterior during polarity establishment and maintenance phases, respectively (57/57 embryos; [Figure 1](#F1){ref-type="fig"}B and Supplemental Movie 1). The appearance of the posterior signal corresponded with the time and location of contact between the sperm pronuclear/centrosome complex and the cortex (best seen in Supplemental Movie 1). This signal then expanded toward the anterior, labeling the posterior, less contractile domain to the extent of the pseudocleavage furrow (similar to the dynamic localization of GFP::PAR-2; [@B10]). On entry into maintenance phase (as the anterior ruffling and pseudocleavage furrow resolve), the CDC-42 activity exhibited a change of localization from the posterior to the anterior cortex. The anterior cortical localization persisted until just before the onset of cytokinetic furrow invagination, when observable cortical enrichment was lost. We refer to the developmental phases associated with the sequential posterior, anterior and noncortical localizations of the probe as phases I, II, and III, respectively. Exogenous coexpression of a constitutively active CDC-42 mutant increases the cortical recruitment during all phases ([Figure 2](#F2){ref-type="fig"} and Supplemental Movie 6).

![Construction, validation, and localization of a biosensor of CDC-42 activity. (A) Alignment of identified GBDwsp-1 (top) with WSP-1 homologues of *C. elegans*, Drosophila, mouse and human (middle), and a probe that reports Cdc42 activity in *Xenopus* (bottom). Boxed amino acids are dissimilar to those of WSP-1. (B) Localization of GFP::GBDwsp-1 in a *control(fRNAi)* embryo. Arrowheads indicate polarized enrichment of cortical signal. From top to bottom: phase I, transition from phase I to phase II, phase II, phase III, completion of cytokinesis. (C) Localization of GFP::GBDwsp-1 in a *cdc-42(fRNAi)* embryo. (D) Yeast two-hybrid showing interaction between GBDwsp-1 and (2) the active CDC-42(Q61L) mutant but not (1) the inactive CDC-42(T17N) mutant, (3) the inactive CED-10(T17N) mutant, (4) the active CED-10(Q61L) mutant, (5) the inactive RHO-1(T19N) mutant, (6) the active RHO-1(Q63L) mutant, or (7) empty-vector control. (8) There is no interaction between the paired empty-vector controls. In these (and all subsequent) micrographs of embryos, the embryo is positioned with anterior to the left and posterior to the right. Bar, 10 μm.](zmk0021093240001){#F1}

![Distribution of active CDC-42 depends upon identified polarity proteins. Embryos expressing GFP::GBDwsp-1 during phases I and II. Embryos from untreated mothers or those depleted of SPD-5, PAR-2 or PAR-6. Also, probe localization in an embryo coexpressing CDC-42(Q61L). Arrowheads indicate polarized enrichment of cortical signal. Bar, 10 μm.](zmk0021093240002){#F2}

Probe Localization Pattern Depends on Known Polarity Factors
------------------------------------------------------------

The posterior CDC-42 activity acts at or downstream of the level of the polarity cue. To confirm that this posterior signal depends upon the sperm-provided polarization cue, we observed the probe in embryos that fail to initiate polarity as a consequence of centrosome maturation failure by depleting SPD-5 by using RNAi. These embryos did not establish a smoothed cortical domain, and the CDC-42 activity was located about the site of the previous polar body extrusion (this small, anterior patch was also transiently observed in wild-type embryos) in phase I ([Figure 2](#F2){ref-type="fig"} and Supplemental Movie 3). These localization patterns resemble those observed with GFP::PAR-2 in severe depletions of centrosomal function ([@B49]). As these embryos developed, the CDC-42 activity of phase II relocalized to the cortical subdomains that were not labeled in phase I. These localization patterns recapitulate those observed with GFP::PAR-6 in severe depletions of centrosomal function (data not shown). Together, our results suggest that CDC-42 cortical activity patterns depend upon centrosome function for determination of anterior and posterior cortical domains in the same way that the polarity proteins PAR-6 and PAR-2 do.

The dynamic localization of CDC-42 activity depends upon the anterior, but not posterior, PAR proteins. Given that active CDC-42 has been demonstrated to interact with PAR-6, we determined whether the localization of CDC-42 activity depended upon the PAR proteins. Depletion of the posterior PAR proteins (PAR-1 or PAR-2) produced little alteration in the dynamic localization pattern \[[Figure 2](#F2){ref-type="fig"} and Supplemental Movie 4 for *par-2(fRNAi)*\]. In these embryos, the probe\'s phase I localization was essentially unchanged, whereas the phase II localization differed only in that it extended further toward the posterior than in the wild type. In contrast, complete embryonic depletion of the anterior PAR complex protein PAR-6 altered both the phase I and II localizations ([Figure 2](#F2){ref-type="fig"} and Supplemental Movie 5). In these embryos, the phase I signal localized weakly and relatively uniformly to the cortex, whereas the phase II signal showed no cortical enrichment. None of these depletions altered the phase III signal (i.e., little cortical signal observed). Together, these results indicate that CDC-42 activity is enriched at the cortical regions that are free of PAR-6 during phase I, then is enriched only at the cortical domains that contain PAR-6 during phase II, and then is not enriched at the cortex during phase III. So, our data suggest that in maintenance phase PAR-6 requires CDC-42 for localization, and CDC-42 activity requires PAR-6 for its localization.

Determination of Regulators of CDC-42 Activity
----------------------------------------------

The dynamic localization pattern of the probe allowed us to identify regulators of CDC-42 activity from a candidate RNAi screen as depletions altering this pattern. Initially, we searched the genomic sequence and identified 18 candidate genes predicted to encode a RhoGEF domain (specifically, tandem DH-PH domains) containing proteins and 22 genes predicted to encode RhoGAP domain-containing proteins (Supplemental Table 1). Gene products of 39 of these 40 were individually depleted: two of these depletions were found to alter probe localization patterns. *tag-150(fRNAi)* embryos (depleted of a putative GEF) exhibited reduced cortical localization of the probe during all developmental time points observed (11/11 embryos; [Figure 3](#F3){ref-type="fig"}). *BE0003N10.2(fRNAi)* embryos (depleted of a putative GAP) exhibited an unaltered probe localization in phase I; however, the phase II localization included an enrichment at both the anterior and poster cortical domains (6/6 embryos; [Figure 3](#F3){ref-type="fig"}). The phase III probe localization in these embryos retained a cortical enrichment, whereas the cortical enrichment is lost at this time in the wild type. The observed loss and gain of apparent CDC-42 activity in depletions of *tag-150* and *BE0003N10.2* are consistent with the sequence predictions that these genes encode a GEF and a GAP, respectively. Deletion mutations predicted to disrupt these genes, *gk261* and *tm1909*, phenocopy the RNAi phenotypes (12/12 for *gk261* and 3/3 for *tm1909*; [Figure 3](#F3){ref-type="fig"} and Supplemental Movies 7 and 8). *tag-150(gk261)* is predicted to disrupt only *tag-150*. This deletion is expected to disrupt encoding of the isoform-conserved RhoGEF domain: it produces a loss of the fourth-to-final exon, encoding part of the DH domain, and a frameshift preventing the expression of the C-terminal PH domain. *BE0003N10.2(tm1909)* is predicted to disrupt the promoters of both that gene and the neighboring *BE0003N10.1* gene, which is predicted to encode a RNA exonuclease. That both *BE0003N10.2(RNAi)* and *tm1909* animals exhibit mislocalization of CDC-42 activity and increased embryonic lethality argues that the cause of the defects in *tm1909* animals is due to the disruption of *BE0003N10.2*. Because loss of *tag-150* affected our probe for CDC-42 activity in ways consistent with its functioning as a GEF for CDC-42, we refer to this gene as *cgef-1* (for *C*DC-42 *g*uanine nucleotide *e*xchange *f*actor). Similarly, because loss of BE0003N10.2 function affected our probe in ways consistent with its functioning as a GAP for CDC-42 and its sequence homology to vertebrate chimaerins, we refer to this gene as *chin-1* (for *Chi*maeri*n*-related).

![Wild-type CDC-42 activity requires the putative GEF CGEF-1 and the putative GAP CHIN-1. (A) Physical map of the portion of the *C. elegans* genome including predicted *cgef-1*--related ORFs, region deleted in the *gk261* mutation, and the target sequence used for *cgef-1(RNAi)*. (B) Physical map of the portion of the *C. elegans* genome including the predicted *chin-1* and *BE0003N10.1* ORFs, region deleted in the *tm1909* mutation, and the target sequence used for *chin-1(RNAi)*. (C) GFP::GBDwsp-1 localization in embryos during phases I, II, and III. Embryos from mothers treated with RNAi directed toward the RhoGEF-encoding *rhgf-1*, *cgef-1*, or *chin-1*. Specificity of RNAi target was tested by comparing the RNAi phenotype to the phenotype of embryos from *cgef-1(gk261)* or *chin-1(tm1909)* mothers. Note the persistence of nuclear signal in *cgef-1(gk261)* embryos. Arrowheads indicate polarized enrichment of cortical signal. Bar, 10 μm.](zmk0021093240003){#F3}

RNAi depletions of CGEF-1 and CHIN-1 did not uncover a polarity defect. Worm strains cultured under conditions of multigenerational *cgef-1(fRNAi)* or *chin-1(fRNAi)* were viable and overtly wild type. In addition, GFP::PAR-2 and GFP::PAR-6 localizations were not grossly altered in the embryos these worms produced (data not shown). These results were surprising given *cgef-1* and *chin-1* were identified as regulators of the activity of CDC-42, which is essential for embryonic and postembryonic development. To test whether the RNAi-mediated depletions were simply insufficient to remove function, *eri-1(mg366)* mutants, which are hypersensitive to exogenous RNAi ([@B27]), were depleted of *cgef-1* or *chin-1* by RNAi. In this sensitized strain, the *chin-1(fRNAi)* animals exhibited sterility within one generation, whereas the *cgef-1(fRNAi)* animals continued to exhibit generally wild-type fecundity, animal morphology, and embryonic cleavage patterns.

Some *cgef-1* function is required for wild-type PAR protein localization dynamics. In the potentially more deleterious *cgef-1(gk261)* background, GFP::PAR-6 retracted further along the A-P axis during phase I than in the wild type and the GFP::PAR-6--labeled domains in these embryos remained abnormally small through phase II (8/8 embryos; [Figure 4](#F4){ref-type="fig"} and Supplemental Movies 9 and 10). At or about the onset of furrowing, the GFP::PAR-6 signal occupied the entire presumptive AB cell cortex, as it does in the wild type. GFP::PAR-2 dynamics were altered in ways that were roughly complementary to those of GFP::PAR-6. Namely, during phase I, the GFP::PAR-2 domain extended abnormally far toward the anterior in phases I and II (9/9 embryos; [Figure 4](#F4){ref-type="fig"} and Supplemental Movies 11 and 12). On furrowing, these embryos exhibited GFP::PAR-2 signal on the presumptive AB cortex that was not seen in *cgef-1(*+*)* embryos. After cleavage, the somatic cells continued to exhibit GFP::PAR-2 signal, which was not observed in the wild type.

![The dynamic localizations of PAR proteins are altered in *cgef-1(gk261)* embryos. GFP::PAR-2 or GFP::PAR-6 localization in embryos from wild-type or *cgef-1(gk261)* mothers. Both PAR proteins are anteriorly displaced through furrow initiation in *cgef-1(gk261)* embryos; however, blastomere-specific segregation is grossly intact by the two-cell stage. Some fluorescence (probably autofluorescence) can be seen. Bar, 10 μm.](zmk0021093240004){#F4}

Putative null mutants of the newly identified CDC-42 regulators exhibited other defects. Like *cgef-1(fRNAi)* embryos, *cgef-1(gk261)* embryos exhibited anteriorly displaced pseudocleavage furrows that persisted longer than in the wild-type. Surprisingly, no other defects in *cgef-1(gk261)* mutant animals or embryos were observed. The brood sizes were wild-type, and embryonic lethality was not statistically significantly elevated ([Table 1](#T1){ref-type="table"}). In contrast, *chin-1(tm1909)* animals exhibited a number of defects. *chin-1*(*tm1909)* animals exhibited both a recessive reduction of brood size and embryonic lethality ([Table 1](#T1){ref-type="table"}), which were cold-sensitive effects. *tm1909* animals also exhibited an abnormal gonad morphology such that the distal gonad arms were enlarged and contained refractive granules in the rachis that were not observed in the wild type (data not shown).

###### 

Observed brood size and embryonic lethality of *cgef-1* and *chin-1* mutant strains

                                          n    Brood size                                      Embryoniclethality (%)
  --------------------------------------- ---- ----------------------------------------------- ---------------------------------------------
  N2 (+/+)                                5    210.8 ± 13.1                                    0.4 ± 0.4
  *cgef-1(gk261)* (−/−)                   5    225.6 ± 9.0                                     1.2 ± 0.8
  N2 (+/+)                                4    337.5 ± 15.4                                    0.7 ± 0.6
  *chin-1(tm1909)*/+                      5    339.8 ± 43.8                                    1.0 ± 0.6
  *chin-1(tm1909)*                        20   7.7 ± 9.5[\*](#TF1-1){ref-type="table-fn"}      98.7 ± 4.1[\*](#TF1-1){ref-type="table-fn"}
  *chin-1(tm1909)* (16°C)                 24   0.04 ± 0.2                                      100 ± 0
  *chin-1(tm1909)* (24°C)                 22   50.7 ± 48.5                                     75.7 ± 20.5
  *chin-1(tm1909);cgef-1(gk261)* (24°C)   11   12.4 ± 13.2[^†^](#TF1-2){ref-type="table-fn"}   79.4 ± 25.0

*chin-1* and *cgef-1* mutant strains were analyzed with experimentally paired observations of the same wild-type strain. Experiments were conducted at 20°C unless otherwise noted. Statistical comparisons noted are for experiments at the same temperature.

\* p \< 0.05, statistically significant difference from the wild type.

^†^p \< 0.05, statistically significant difference from *chin-1(tm1909)* at 24°C.

*cgef-1(gk261)* mutants exhibited unexpectedly mild phenotypes, especially compared with depletions or deletions of *cdc-42*, so we tested for residual CGEF-1 function and possible redundant CDC-42 GEFs in these mutants. First, we determined that the *gk261* phenotypes of slightly increased embryonic lethality and reduction of cortical recruitment of GFP::GBDwsp-1 were not more severe in *cgef-1(gk261* + *RNAi)* strains (data not shown). Therefore, we suspect that *gk261* is a null allele of *cgef-1*. Functional redundancy with other RhoGEFs was tested by scoring for enhancement of sterility or embryonic lethality by *gk261* in worms that were depleted of the 17 other predicted RhoGEF gene products (Supplemental Table 2). The *gk261* alleles enhanced the embryonic lethality observed in several of the GEF-depleted lines and reduced the brood size of a few others. Relative to *gk261* animals, two of these RNAi treatments---directed against putative GEFs *tag-127* and *R02F2.2*---markedly increased the embryonic lethality. These two depletions were repeated in *gk261* worms expressing GFP::GBDwsp-1, and the observed signal localization was indistinguishable from the undepleted controls (data not shown). In addition, logistic regression analysis suggests that *cgef-1* and *C11D9.1* may serve overlapping essential functions and that *cgef-1* and *rhgf-1* may serve antagonistic functions in some essential process (Supplemental Table 2). Unfortunately, the brood reductions observed in *cgef-1(gk261)* animals depleted of R02F2.2 or TAG-127 were sufficiently severe to limit the statistical power of demonstrating interaction of *cgef-1* with either of those two genes.

Localization of the Putative CDC-42 GAP and GEF
-----------------------------------------------

Because CHIN-1 depletions affected the spatial patterning of the CDC-42 activity biosensor, we speculated that CHIN-1 itself might exhibit a polarized cortical distribution. GFP::CHIN-1, expressed under germline regulatory control, localized to the centrosomes, pronuclei, central spindle and cell cortex in the early embryo ([Figure 5](#F5){ref-type="fig"}A). This reporter strain exhibited no cortical enrichment during phase I but was recruited to the posterior cortex both in a diffuse pattern and in discrete puncta phase II (23/23 embryos). These puncta flowed into the ingressing cleavage furrow during phase III (Supplemental Movie 13). In older embryos, signal was observed at cell borders, nuclei and centrosomes (data not shown). *cdc-42(fRNAi)* (3/3 embryos), *par-3(fRNAi)* (3/3 embryos), *pkc-3(fRNAi)* (3/3 embryos), and *par-6(fRNAi)* (7/7 embryos) embryos exhibited a similar distribution pattern of GFP::CHIN-1 as the wild type, except that the phase II cortical localization in these embryos was not restricted to the posterior ([Figure 5](#F5){ref-type="fig"}B and Supplemental Movies 14 and 15; *par-3 and pkc-3* depletions not shown). *par-1(fRNAi)* embryos showed the same localizations as the wild type with the exception that the posterior, cortical localization during phase II was restricted to a smaller domain (3/3 embryos; [Figure 5](#F5){ref-type="fig"}B and Supplemental Movie 16). Interestingly, *par-2(fRNAi)* embryos exhibited a different phase II localization than did *par-1(fRNAi)* embryos. In *par-2(fRNAi)* embryos, GFP::CHIN-1 localized only to the extreme posterior cortex throughout phase II (7/7 embryos; [Figure 5](#F5){ref-type="fig"}B and Supplemental Movie 17). This observation suggests that PAR-2 is required to recruit CHIN-1 to the cortex via a mechanism that is independent of PAR-1. Unexpectedly, GFP::CHIN-1 signal is dramatically reduced in the germlines of *par-5(fRNAi)* animals and their embryos (3/3 animals; [Figure 5](#F5){ref-type="fig"}B). Together, these observations suggest that PAR-2 stabilizes CHIN-1 at the posterior cortex during phase II.

![Localization of GFP::CHIN-1 depends on CDC-42, PAR-6 and PAR-2 but not PAR-1. Embryos expressing GFP::CHIN-1 in the early embryo. (A) Optical sections through the middle of the cell. GFP::CHIN-1 localizes to the cytoplasm, centrosomes (black arrowheads), central spindle, cortical puncta (white arrowheads) and some structures suggestive of P-granules (white arrows). The cortical puncta are only observed in the early embryo at the posterior during phase II and at the posterior during the late two-cell stage. (B) Optical sections through the cortex of the cell. Cortical localization depends upon some polarity proteins. Embryos depleted of CDC-42 or PAR-6 exhibit puncta all about the cortex in phase II. Embryos depleted of PAR-2 exhibit cortical puncta only at the extreme posterior, whereas those depleted of PAR-1 exhibit only a slight reduction of the posterior domain that contains puncta. No depletion altered the absence of puncta in phase I. Embryos depleted of PAR-5 exhibited a dramatic reduction in GFP::CHIN-1 signal and an absence of cortical puncta. (C) Optical sections through the middle of the cell. Anti-CHIN-1 antibody localizes as posterior cortical puncta during phase II. This localization is lost in *chin-1(RNAi)* embryos. Bar, 10 μm.](zmk0021093240005){#F5}

Because the GFP::CHIN-1 transgene is driven by *pie-1* regulatory elements, it is possible that it reports a spurious localization. However, the endogenous protein is probably expressed in the germline (and most other cell types) as a *chin-1* promoter drives expression of GFP in the germline and most cells of adults and larvae ([@B22]). The localization of endogenous CHIN-1 by immunolocalization recapitulates the cytoplasmic and cortical localization of the transgene with no cortical localization during phase I (0/4 embryos), posterior cortical localization in phase II (6/7 embryos) and posterior cortical localization of P~1~ cells in late prophase and anaphase (5/5 embryos; [Figure 5](#F5){ref-type="fig"}C). *chin-1(fRNAi)* embryos exhibited no unequivocal cortical puncta in phase II (0/13 embryos; [Figure 5](#F5){ref-type="fig"}C) or the late two-cell stage (0/8 embryos).

CGEF-1 depletions affected the cortical enrichment but not the spatial patterning of the CDC-42 biosensor. Nevertheless, the intracellular localization of CGEF-1, the a and c isoforms of which are probably expressed in the gonad ([@B54]), might clarify mechanisms of CDC-42 activation. We found that GFP::CGEF-1A expressed under germline regulatory control localized to the cytoplasm and was enriched in the nucleoplasm and cell cortex (Supplemental Figure 3; best seen in Supplemental Movie 2). Unfortunately, the two independent transformant strains we obtained did not express at sufficient levels for unequivocal localizations. CGEF-1 immunolocalization with an antibody raised against the C-terminal portion encoded by all *cgef-1* isoforms was unsuccessful (data not shown).

CDC-42 and RHO-1 Signaling Differentially Direct Cortical Recruitment of Nonmuscle Myosin II
--------------------------------------------------------------------------------------------

Wild-type embryos, before the onset of cortical polarity, localize the nonmuscle myosin II NMY-2 and associated proteins to cortical foci, where they ruffle the cell surface. This process requires RHO-1, its activating GEF ECT-2 and the myosin subunit MLC-4 ([@B9]). On transmission of the polarizing signal from the sperm centrosome, we observe that NMY-2 foci were lost locally, and the remaining asymmetric NMY-2 apparently retracted the cortex toward the anterior, producing a pseudocleavage furrow at about half of the embryo\'s length ([Figure 6](#F6){ref-type="fig"}, Supplemental Figure 5, and Supplemental Movie 18 \[39/39 embryos; [@B30]\]). This pseudocleavage furrow and anterior ruffling resolved as the NMY-2 foci dissipated, concomitant with entry into phase II. During phase II, NMY-2 localized as smaller puncta that were asymmetrically localized at the anterior cortex (also reported by [@B40]). These puncta exhibited some cortical flow toward the anterior pole and produced a local enrichment at the posterior edge of this domain in a manner reminiscent of the local enrichment at the pseudocleavage furrow in phase I. This anterior cortical NMY-2 localization was lost before the recruitment of NMY-2 into phase I-like foci at the equatorial cortex during phase III. These foci condensed into the contractile ring that cleaved the cell.

![RHO-1 and CDC-42 pathway components are required to recruit GFP::NMY-2 to the cortex in distinct phases. Optical sections through the cell cortex of embryos expressing GFP::NMY-2 in the early embryo. In the wild type, GFP::NMY-2 localizes to the cortex in distinct morphological distributions in phases I and II. The robust myosin foci observed in phase I depend upon ECT-2, RHO-1, and LET-502 \[represented here by *let-502(fRNAi)*\]. The robust, diffuse, and polar distribution of smaller myosin puncta in phase II depends upon CGEF-1, CDC-42, and MRCK-1 \[represented here by *mrck-1(ok586*)\]. Disruption of either pathway does not abolish the recruitment by the other, and disruption of both pathways disrupts both recruitment patterns. Shown here are embryos from wild-type, *mrck-1(ok586)*, *let-502(fRNAi)*, and *ect-2(fRNAi)*; *cdc-42(fRNAi)* mothers. Embryos from each of the six single disruptions are presented in Supplemental Figure 3. Bar, 10 μm.](zmk0021093240006){#F6}

Disrupting CDC-42 signaling did little to the phase I localization of NMY-2 but did affect its phase II localization. Although most published defects in *cdc-42(RNAi)* embryos occur during phase II, the posterior enrichment we observed in our CDC-42 activity biosensor suggested that CDC-42 may play a role during the phase I cortical flows. To determine the biological significance of the posterior phase I localization of the active CDC-42 probe, we used RNAi to deplete candidate CDC-42 effectors. Phase I cortical flow rates were measured as described previously ([@B30]) in the background of our *gfp::nmy-2* transgene with embryonic expression driven by a *pie-1* promoter. In contrast to a published finding ([@B29]), *cdc-42(fRNAi)* embryos did not exhibit a significantly reduced flow rate. Few of the CDC-42 upstream regulator or effector depletion conditions tested (Supplemental Figure 4) detectably altered the average rates of individual foci, though *par-1(fRNAi)* and *wve-1(fRNAi)* treatments increased flow rates. However, *cgef-1(fRNAi)*, *cdc-42(fRNAi)* and *tag-59(fRNAi)* embryos exhibited a striking, reduced GFP::NMY-2 localization to the anterior cortex during phase II. This effect of *cdc-42(RNAi)* has been reported previously ([@B40]). *tag-59* has homology to vertebrate myotonic dystrophy-related Cdc42 binding kinase, so we refer to *tag-59* as *mrck-1* (for *m*yotonic dystrophy-*r*elated *C*dc42 binding *k*inase homologue). The phase II cortical recruitment of GFP::NMY-2 was nearly abolished in *cgef-1(gk261)* (8/8 embryos), *cdc-42(fRNAi)* (14/14 embryos) and *mrck-1(fRNAi or ok586)* embryos (2/19 *RNAi* and 7/7 *ok586* embryos) ([Figure 6](#F6){ref-type="fig"}, Supplemental Figure 5, and Supplemental Movies 19--21). These observations suggest a pathway by which CGEF-1 activity produces a recruitment of NMY-2 to the cortex via the actions of CDC-42 and the kinase MRCK-1 during phase II. Further supporting this hypothesized pathway, depletion of CHIN-1 produces an increase of NMY-2 recruitment. In *chin-1(fRNAi)* embryos, the phase I myosin localization seems unaltered; however, the diffuse myosin recruited to cortex in phase II is spatially expanded toward the posterior (Supplemental Figure 5).

In contrast to the effects of disrupting the CDC-42 pathway, disrupting a putative RHO-1 pathway produces defects primarily in establishment phase/phase I ([@B24]; [@B29]; [@B40]; [@B38]; [@B39]). We reproduced the experimental result that depletions of the putative RHO-1 GEF ECT-2 (3/3 embryos) or RHO-1 (2/2 embryos) itself reduce cortical recruitment of NMY-2 to the cortex in phase I (Supplemental Figure 5 and Supplemental Movies 22--23). To expand upon these findings, we depleted candidate RHO-1 effectors and identified LET-502, a previously described Rho-binding kinase ([@B51]), as a likely effector linking RHO-1 signaling to NMY-2 recruitment. *let-502(fRNAi)* embryos were found to have reduced cortical GFP::NMY-2 recruitment in phase I ([Figure 6](#F6){ref-type="fig"}, Supplemental Figure 5, and Supplemental Movie 24) (7/8 embryos), reduced average speeds of foci movement during cortical flow (Supplemental Figure 4), and dramatically reduced cortical retraction. Together with previously published results, this observation suggests a pathway by which ECT-2 activity produces a recruitment of NMY-2 to the cortex via the actions of RHO-1 and LET-502 during phase I. Although *cyk-1(fRNAi)* embryos exhibited marked increased maximum cortical flow puncta speeds (Supplemental Figure 4), this treatment did not disrupt the overall developmental pattern of cortical flows.

Embryos that failed to localize NMY-2 to the anterior in phase I because of a Rho pathway defect, nonetheless localized NMY-2 to the anterior in phase II. Embryos depleted of ECT-2, RHO-1, or LET-502 exhibited reduced cortical flows during phase I, but the production of a myosin-enriched domain at the anterior by the end of phase II occurred ([Figure 6](#F6){ref-type="fig"}, Supplemental Figure 5, and Supplemental Movies 22--24) nonetheless. Given that the morphology of the phase II, cortical NMY-2 signal in Rho pathway-depleted embryos resembles that of the wild-type phase II morphology, we assayed cortical myosin recruitment in embryos depleted of both a Rho and Cdc42 pathway member. Simultaneous disruption of both the Rho and Cdc42 pathways produced a loss of both phase I and phase II myosin recruitment ([Figure 6](#F6){ref-type="fig"}, Supplemental Figure 5, and Supplemental Movie 25). This suggests that the Rho pathway is active during phase I and that the Cdc42 pathway is active in phase II.

DISCUSSION
==========

Utility of Localizing Protein Signaling Activity
------------------------------------------------

The localization of CDC-42 activity that we observed does not correlate with the localization of either CDC-42 or its fixed-activity mutant forms. Previous studies demonstrated that CDC-42 is not required for the cortical recruitment of the anterior PAR complex during phase I in the *C. elegans* early embryo but is required for its maintenance during phase II ([@B15]; [@B29]). That a GFP-tagged mutant PAR-6 defective for CDC-42-binding in *cdc-42(*+*)* exhibits the same localization patterns in phase I as wild-type PAR-6 in *cdc-42(RNAi)* embryos suggests that PAR-6 can be localized specifically to the anterior cortex without directly interacting with CDC-42. However, this mutant PAR-6 is lost from the cortex in phase II, just about when our probe reports increased CDC-42 activity at that location ([@B1]). The active CDC-42 probe reports anterior cortical activity specifically during the period that PAR-6 requires interaction with active CDC-42 for cortical localization, suggesting that both PAR-6 and the probe can access the pool of active CDC-42 during phase II. The dynamics of recruitment of this probe indicates that anterior activation of CDC-42 occurs only in phase II. However, it is possible that activation occurs also in phase I, but that active CDC-42 may be masked from the probe during this time by competitively binding PAR-6. Although we cannot eliminate the second possibility, it seems unlikely that such a competition would occur in phase I but not phase II, when PAR-6 requires CDC-42 to remain enriched at the cortex. Under either scenario, our observation of the localization of endogenous CDC-42 activity suggests several interesting possibilities: between phases I and II there is an increase in the anterior cortical activity of CDC-42; there is a substantive, but as yet unnoticed reduction in anterior PAR protein concentration; or the anterior PAR complex\'s binding to active CDC-42 becomes less tight.

The Phase II Balance of the PAR Proteins Regulates, and Is Regulated by, CDC-42 Activity
----------------------------------------------------------------------------------------

Previous work has shown that cortical flows establishing polarity in the *C. elegans* one-cell embryo do not determine the position of first cleavage. Embryos depleted of RHO-1--oriented GAPs exhibit exaggerated cortical flows during phase I that produce small anterior domains ([@B38]; [@B39]). These exaggerated flows, however, alter neither the ultimate relative size of the polarized domains nor the site of first cleavage. By contrast, we found that depletion of the putative CDC-42 GAP CHIN-1 produced an enlarged anterior cortical domain.

We propose that the anterior PARs engage in a negative regulatory feedback loop with PAR-2 and the putative CDC-42 GAP CHIN-1. In this model, the anterior PAR proteins and CDC-42 are enriched at the anterior by phase I cortical flows as proposed previously ([@B30]). During maintenance phase ([Figure 7](#F7){ref-type="fig"}), some timing cue recruits CHIN-1 to the cortex, which is destabilized at the cortex by the anterior PAR complex. Anterior PAR complexes that migrate into the posterior are destabilized by CHIN-1--mediated inactivation of CDC-42. This model is insufficient to fully describe the mutually antagonistic relationship between the two sets of PAR proteins. PAR-1 depletions result in an expanded anterior domain during phase II ([@B10]; [@B18]) but do not prevent the cortical recruitment of CHIN-1. Therefore, the regulation of CDC-42 activity must be in a pathway redundant to the mutual antagonism mediated by the phosphorylation of PAR-3 by PAR-1 and of PAR-1 by PKC-3 ([@B23]; [@B46]; [@B18]) that causes cortical loss of the phosphorylated proteins. Interestingly, both of these proposed pathways incorporate PAR-5, which is necessary to stabilize CHIN-1 and to mediate cortical exclusion of certain phosphorylated PAR proteins. The redundant regulatory path provided by this model explains an observation that is otherwise difficult to explain, namely, that ectopic expression of CDC-42(Q61L) expands the PAR-6-labeled anterior domain ([@B1]). This mutant form of CDC-42 would not be subject to inactivation by the posterior GAP activity and could therefore bias the regulatory balance of the contested border of the two PAR domains in favor of the anterior complex.

![Model of CDC-42activity regulation in phase II polarity maintenance. Here, regulatory associations are positive for arrows and negative for crossed lines. Gray associations are not operative, whereas dark associations are operative. For a fuller description of the model, see *Discussion*.](zmk0021093240007){#F7}

Spatial restriction of CDC-42 activity also plays a key role in the polarization of cells in other contexts. The establishment of "inner-outer" PAR asymmetry of embryonic blastomeres later in development also requires the restriction of CDC-42 activity by the action of the GAP PAC-1 ([@B2]). In budding yeast, the GEF Cdc24 is strictly required to recruit Cdc42 to the cortex and for initiation of budding ([@B32]), whereas the GAP Rga1 is required to restrict this bud selection site from the previous bud scar ([@B48]). In the Drosophila neuroblast, Cdc42 activity is required to prevent the expansion of the basal determinants, whereas the constitutively active Cdc42 mutant expands the apical domain to the entire cortex ([@B3]). Given that no identified basal component is required to restrict apical component in the way that PAR-1 and PAR-2 exclude the anterior PARs in *C. elegans*, this raises the prospect that an unidentified Cdc42 GAP may serve this function in the Drosophila neuroblast.

The developmental timing of CHIN-1 recruitment to cortical puncta suggests that its mobilization is under significant regulatory control at the transition from phase I to phase II. In this study, we did not identify upstream regulators of this transition. As CHIN-1 is predicted to encode a C2 domain, we tested whether depleting phospholipase C-encoding gene products might affect the localization of CHIN-1. Individual RNAi-mediated depletions of *plc-1*, *plc-2*, *plc-3*, *plc-4*, and *egl-8* did not alter the localization of GFP::CHIN-1 in the embryos examined (n = 2 each condition; data not shown). We speculate that identifying cell regulators of CHIN-1 cortical recruitment may mechanistically link the phase I-to-phase II timing cue and the spatial regulation of PAR protein polarity.

RHO-1 and CDC-42-mediated Pathways Independently Direct Anteriorward Cortical Flows
-----------------------------------------------------------------------------------

In the early embryo, the polarization initiated by the sperm centrosome is spatially elaborated by a myosin II-powered cortical flow regulated by RHO-1 signaling ([@B9]). Although this flow is essential for establishing the PAR protein polarity, it does not determine the size of the PAR-labeled domains at cleavage ([@B10]; [@B38]; [@B39]). The refinement of this boundary between PAR domains occurs at the same time that actin and myosin exhibit anteriorly restricted cortical localizations ([@B40]; [@B50]). That this second, polarized myosin distribution requires CDC-42 ([@B40]) suggests that these might represent accumulations of myosin in response to distinct G protein-mediated signals. Indeed, we observed that these two phases of asymmetric myosin enrichment occur independently as consequences of signals mediated by ECT-2, RHO-1, and LET-502 in phase I and CGEF-1, CDC-42, and MRCK-1 in phase II ([Figure 6](#F6){ref-type="fig"}). This second, anteriorly localized accumulation of the actomyosin cortex may provide a mechanism, perhaps redundantly with unequal strength of mutual PAR antagonism, to refine the boundary of polarized domains during phase II that ultimately determine the cleavage plane and blastomere size. How the PAR-dependent spatial information is propagated to spindle positioning proteins such as LET-99, GPR-1/2 and LIN-5 is not understood at a mechanistic level. Our observation that regulation of CDC-42 signaling can alter the size of the myosin-enriched anterior domain provides another potential mechanism by which this positioning information can be transduced. It should be interesting to determine to what extent this polarized recruitment of NMY-2 affects the observed refinement of the boundary defined by segregation of the PAR proteins. The identification of MRCK-1 as a mediator of CDC-42--dependent myosin recruitment might allow a dissection of a specific role for NMY-2 in the refinements of PAR polarity observed in phase II. The speculation that CDC-42 might play a conserved role in regulating cortical determinant segregation through actinomyosin regulation is consistent with the observation that Cdc42p organizes the assembly of actin cables by which polarized transport of a spindle pole and cell fate determinants occur in Saccharomyces cerevisiae (reviewed in [@B34]). Also, in the Drosophila neuroblast model system, Cdc42 localizes to an apical cap where the enrichment of myosin II is required to restrict basal determinants to the basal cortex ([@B4]; [@B3]). Further work will define the role of the CDC-42-dependent, phase II actin and myosin enrichments in the refinement of polarity during this phase of polarization in the early *C. elegans* embryo.
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